Clinical Trials Logo

Acute Blood Loss Anemia clinical trials

View clinical trials related to Acute Blood Loss Anemia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05081063 Completed - Clinical trials for Traumatic Brain Injury

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

Start date: March 5, 2022
Phase: Phase 3
Study type: Interventional

Adult male patients brought to the emergency department as Level A trauma activations who are receiving emergency blood transfusion. Objectives 1. Evaluate PRBC equivalents transfused in each group in the first 24 hours (Primary outcome) 2. Evaluate total transfusion in each group in the first 24 hours (Secondary Outcome) including breakdown by FFP equivalents, platelet units, and cryoprecipitate 3. Evaluate 6 hour, 24 hour, and hospital mortality (Secondary Outcome) 4. Evaluate ICU outcomes in each group

NCT ID: NCT02877381 Completed - Clinical trials for Acute Blood Loss Anemia

Tranexamic Acid in Revision Total Joint Arthroplasty

Start date: April 2016
Phase: Phase 4
Study type: Interventional

To determine the optimal dosing regimen and route of administration of tranexamic acid (TXA) [single dose intravenous (IV), double dose intravenous, intravenous + topical, and oral repeated dosing] to minimize post-operative blood loss and transfusion requirements following revision total knee arthroplasty (RTKA).

NCT ID: NCT01683955 Completed - Osteoarthritis, Hip Clinical Trials

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

Start date: January 1, 2013
Phase: Phase 1
Study type: Interventional

This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.

NCT ID: NCT01370460 Completed - Clinical trials for Osteoarthritis, Knee

Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty

Start date: June 2011
Phase: Phase 2
Study type: Interventional

This study aims to assess postoperative blood loss and transfusion rates in total knee replacement after one-time administration of topical tranexamic acid.